AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
20.58
+1.52 (7.97%)
Apr 17, 2025, 4:00 PM EDT - Market closed
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $630.20 million as of April 17, 2025. Its market cap has increased by 13.65% in one year.
Market Cap
630.20M
Enterprise Value
614.29M
1-Year Change
13.65%
Ranking
Category
Stock Price
$20.58
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $630.20M, an increase of 104.15%. That is a compound annual growth rate of 9.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 630.20M | 56.42% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.22B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.41B |
| AbbVie | 306.03B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |